EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Donor-Derived Cell-Free DNA as a Non-Invasive Readout of Activity Across the Rejection Continuum

Louise Benning, Aylin Akifova, Bilgin Osmanodja, Christian Morath, Julia Beck, Ekkehard Schütz, Klemens Budde

Transplant International · 24.02.2026 · 39

DOI: 10.3389/ti.2026.16099 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Transplant International, online erschienen am 24.02.2026. Verfasst von Louise Benning und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Heidelberg University Hospital, Heidelberg, Germany. Hauptthemen laut MEDLINE: Graft Rejection, Cell-Free Nucleic Acids, Kidney Transplantation. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Recent work demonstrated that kidney allograft rejection unfolds along a biological continuum that can be quantified using histopathology-derived continuous indices. To investigate whether donor-derived cell-free DNA (dd-cfDNA) reflects this rejection continuum and complements these histopathology-derived indices, we analyzed the association between dd-cfDNA measures and the newly developed rejection indices in 249 indication biopsies from two independent cohorts. dd-cfDNA was analyzed as percentage, absolute copies/mL, and as a previously developed combined continuous model (CM) score integrating both measures to mitigate limitations of relative measurements. dd-cfDNA increased with histopathological activity and was highest in biopsies with microvascular inflammation (MVI), including antibody-mediated (AMR) and mixed rejection, paralleling high AMR/MVI and activity indices. T-cell-mediated rejection (TCMR) showed elevated TCMR/tubulointerstitial inflammation (TI) indices but lower and more variable dd-cfDNA, accompanied by increased total cfDNA, providing a plausible explanation for the reduced detectability of low-grade TCMR when dd-cfDNA is expressed as a percentage alone. Interclass correlation analyses revealed the strongest associations between dd-cfDNA and the AMR/MVI and activity indices. The combined CM score achieved the highest overall associations (sum R 2 = 3.4), outperforming absolute and relative dd-cfDNA measures. Thus, dd-cfDNA may serve as a non-invasive readout of graft inflammation and extends the rejection-continuum concept into the non-invasive space.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Graft RejectionCell-Free Nucleic AcidsKidney TransplantationHumansFemaleMaleMiddle AgedAdultBiopsyTissue DonorsBiomarkersT-LymphocytesInflammationKidney

Stichwörter der Autor:innen

dd-cfDNAdonor-derived cell-free DNAkidney transplantationrejectionrejection continuum

Substanzen

Cell-Free Nucleic AcidsBiomarkers

Autor:innen und Institutionen

  • Department of Nephrology, Heidelberg University Hospital, Heidelberg, Germany.
  • Department of Nephrology and Intensive Care, Charité Universitätsmedizin Berlin, Berlin, Germany.
  • Department of Nephrology and Hypertension, Klinikum Nuremberg, Paracelsus Medical University, Nuremberg, Germany.
  • Chronix Biomedical GmbH, Göttingen, Germany.
  • Insight Molecular Diagnostics Inc., Nashville, TN, United States.

Zitieren

APA

Benning, L., Akifova, A., Osmanodja, B., Morath, C., Beck, J., Schütz, E., & Budde, K. (2026). Donor-Derived Cell-Free DNA as a Non-Invasive Readout of Activity Across the Rejection Continuum. Transplant International, 39. https://doi.org/10.3389/ti.2026.16099

Vancouver

Benning L, Akifova A, Osmanodja B, Morath C, Beck J, Schütz E, et al. Donor-Derived Cell-Free DNA as a Non-Invasive Readout of Activity Across the Rejection Continuum. Transplant International. 2026;39. doi:10.3389/ti.2026.16099

BibTeX
@article{Benning2026,
  author = {Benning, Louise and Akifova, Aylin and Osmanodja, Bilgin and Morath, Christian and Beck, Julia and Schütz, Ekkehard and Budde, Klemens},
  title = {Donor-Derived Cell-Free DNA as a Non-Invasive Readout of Activity Across the Rejection Continuum},
  journal = {Transplant International},
  year = {2026},
  volume = {39},
  doi = {10.3389/ti.2026.16099}
}
Kostenlos starten →